Global (English)
In the operating room, every decision a neurosurgeon makes can have profound implications for the patient’s prognosis. Yet in most centers, imaging follow-up is still performed only post-operatively, when MRI reveals—sometimes too late—whether the lesion has been completely resected.
Every year, more than 250,000 new cases of primary malignant brain tumors are diagnosed worldwide1, 77% of which are gliomas. These tumors are notoriously difficult to differentiate from adjacent brain tissue, making it difficult to accurately estimate residual tumor during surgery2.
Intraoperative MRI with I-Genius transforms the practice of brain tumor surgery by allowing MR imaging directly in the operating room, eliminating patient transfer and giving surgeons greater confidence in achieving a more complete and safer resection.
A new era of neurosurgery has begun.
See more.
When it matters.
Every move in the operating room can change a life. With I-Genius, Esaote brings MRI directly into the operating room, providing images without moving the patient. More than just a tool, it ensures safety, precision, and the confidence that comes from having immediate post-operative follow-up - before the patient even leaves the operating room.
The patient stays.
The future moves.
With I-Genius, neurosurgeon can perform both surgical and MRI procedures on a single integrated bed system.
This approach marks a revolutionary breakthrough in neurosurgical methodology and makes it possible to streamline clinical workflows, improve patient safety, and maintain sterile conditions.
The same workflow, only simpler and safer.
With i-Genius, there's no need to change your surgical routine: MRI is fully integrated into your surgical workflow. It’s safer because the patient remains in the ideal position, without ever being moved, and faster because you can check the outcome immediately without interrupting the procedure.
Designed for the operating room
I-Genius has been conceived to work seamlessly in the delicate environment of the OR. Its low-field technology ensures safety in terms of emissions and sterility requirements, while its compact design allows full compliance with surgical space. A solution created not just to fit in the operating room, but to belong there.
“With I-Genius we bring MRI into the operating room for the first time, making neurosurgery simpler, safer, and more effective. With over 40 years of experience in MRI solutions, Esaote reaffirms its commitment to tailored solutions that truly change clinical practice.”
Massimo Olmi
MRI Strategic Marketing Director
Ready to experience I‑Genius in action @EANS 2025?
Esaote will present I-Genius through a dedicated workshop at EANS Congress 2025, offering participants an exclusive preview of the solution.
Developed with neurosurgeons, backed by evidence.
Roberto Rafael Herrera
MD
"For more than two decades, neurosurgeons around the world have dreamed of the perfect intraoperative MRI — compact, efficient, safe, and truly integrated into the surgical workflow. That dream is now becoming reality. i-GENIUS is not just another intraoperative MRI; it is the result of years of research, surgical experience, and the vision of those who believed that brain tumor surgery could and should be safer. With i-GENIUS, high-quality imaging arrives directly into the operating room, without interruptions, exactly when it is needed. This breakthrough means neurosurgeons can finally see what they are doing, in real time, where it matters most. Intraoperative MRI did not fail — it was only waiting for the right solution. i-GENIUS is that solution. A new era in neurosurgery begins now."
Intraoperative MRI in Brain Glioma Surgery Using Low-field system
Presentation of the First Twenty-eight Procedures
Roberto Rafael Herrera, MD; José Luis Ledesma, MD; Héctor Pablo Rojas, MD; Francisco Sanz, MD; Juan Martin Herrera, MD; Ariel Estramiana, MD; Juan Santiago Bottan, MD
Fill out the form to get the workshop recording as soon as it’s ready
References
1Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2011–2015. Neuro Oncol. 2018;20(suppl_4):iv1–iv86. doi:10.1093/neuonc/noy131.
2Soma S, Tamura A, Shibao S, Nishino S, Iwama T. Significance of intraoperative magnetic resonance imaging in glioma surgery. Neurol Med Chir (Tokyo). 2021;61(2):63–9. doi:10.2176/nmc.ra.2020-0207.
